Medirom Healthcare Technologies Inc (MRM) — Cash Flow Reinvestment Rate

Latest as of March 2024: 2.86x

Medirom Healthcare Technologies Inc (MRM) has a Cash Flow Reinvestment Rate of 2.86x as of March 2024, reinvesting $79.60 Million (capex $79.60 Million ) from operating cash flow of $27.79 Million. Check earnings quality score of Medirom Healthcare Technologies Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

2.86x
(Capex + Investments) / Operating CF

Total Reinvested

$79.60 Million
Capex + Investments

Operating Cash Flow

$27.79 Million
USD

Capital Expenditures

$79.60 Million
USD

Medirom Healthcare Technologies Inc Cash Flow Reinvestment Rate (2018–2019)

Historical reinvestment intensity for Medirom Healthcare Technologies Inc across 2 annual periods. Explore MRM long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Medirom Healthcare Technologies Inc (2018–2019)

Year-by-year capital reinvestment analysis for Medirom Healthcare Technologies Inc. For live market cap and broader valuation context, see Medirom Healthcare Technologies Inc (MRM) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 6.72x $52.85 Million $7.87 Million $7.41 Million ▲ +738.0%
2018 0.80x $113.69 Million $141.87 Million $34.30 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow